Note 14 - Reportable Segments - Reconciliation of Reportable Segment Net Income (Loss) to Consolidated Net Income (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Net income of reportable segments		$ 164	$ 208	$ 621	$ 1,352
Gain (loss) on foreign currency hedges related to translated earnings		20	(68)	128	257
Research, development, and engineering expenses (1)		(270)	(278)	(787)	(766)
Amortization of intangibles		(30)	(31)	(92)	(92)
Interest expense, net		(82)	(73)	(239)	(216)
Provision for income taxes (Note 3)		(35)	(34)	(178)	(380)
Severance charges (2)				(86)	(8)
Gain on sale of business					53
Other corporate items		(33)	(106)	(128)	(391)
Operating Segments [Member]
Net income of reportable segments		509	561	1,499	1,771
Research, development, and engineering expenses (1)		(222)	(235)	(640)	(651)
Provision for income taxes (Note 3)		140	153	412	483
Operating Segments [Member] | Reportable Segments [Member]
Net income of reportable segments		517	543	1,465	1,736
Operating Segments [Member] | Nonreportable Segments [Member]
Net income of reportable segments		(8)	18	34	35
Segment Reconciling Items [Member]
Net income of reportable segments		164	208	621	1,352
Impact of constant currency reporting (1)		(212)	(136)	(535)	(319)
Gain (loss) on foreign currency hedges related to translated earnings		20	(68)	128	257
Translation gain on Japanese yen-denominated debt		35	84	162	321
Litigation, regulatory and other legal matters		(32)	(23)	(44)	(65)
Research, development, and engineering expenses (1)	[1]	(40)	(43)	(127)	(115)
Amortization of intangibles		(30)	(31)	(92)	(92)
Interest expense, net		(62)	(59)	(179)	(180)
Provision for income taxes (Note 3)		105	119	234	103
Severance charges (2)	[2]	(13)	(8)	(86)	(8)
Disposal of assets and other charges and credits (3)	[3]	(59)	(130)	(184)	(209)
Gain on sale of business					53
Other corporate items		$ (57)	$ (58)	$ (155)	$ (165)

[1] Amount does not include research, development, and engineering expense related to restructuring, impairment and other charges and credits.

[2] For the three and nine months ended September 30, 2023, the amount recorded in cost of sales in the consolidated statements of income was $10 million and $51 million, respectively. For the three and nine months ended September 30, 2022, the amount recorded in cost of sales in the consolidated statements was not material.

[3] For the three and nine months ended September 30, 2023, the amount recorded in cost of sales in the consolidated statements of income was $53 million and $145 million, respectively. The activity primarily related to asset write-offs during the period. For the three and nine months ended September 30, 2022, the amount recorded in cost of sales in the consolidated statements of income was $124 million and $192 million, respectively. The activity primarily related to capacity optimization of an emerging growth business.